(en) With a better understanding of head and neck cancer (HNC) pathogenesis and the identification of good-prognosis subtypes, such as HPV-positive tumors, there is an urgent need to better identify patients who may avoid overtreatment and unnecessary toxic effects. [...]
Bossi, P., Seront, E., & Machiels, J.-P. (2019). May we rely on induction chemotherapy again as a biological selection of radiosensitive head and neck cancer? Oral Oncology, 94(1), 121-122. https://doi.org/10.1016/j.oraloncology.2019.05.011 (Original work published 2019)